Secondary cancers after a lung carcinoid primary: A population-based analysis

Lung Cancer

Volumn 52, Issue 3, 2006, Pages 273-279

  Cote, M L ^a   Wenzlaff, A S ^a   Philip, P A ^b   Schwartz, A G ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Epidemiology; Lung carcinoid; Neuroendocrine tumor; Population based; Second primary cancer; SEER

Indexed keywords

HORMONE; SEX HORMONE;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOID; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MELANOMA; METASTASIS; PANCREAS CANCER; PATIENT INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; STANDARDIZATION;

BREAST NEOPLASMS; CARCINOID TUMOR; FEMALE; HISTORY, 20TH CENTURY; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 33646344202     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.02.004     Document Type: Article

References (27)

1. *Stat Database: Incidence-SEER 9 Regs Public-Use, November 2003 Sub (1973-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004. Based on the November 2003 submission, 2004.
2. Hamperl H. Uber gutartige bronchilatumoren cylindrome und carcinoid. Virchows Arch 300 (1937) 46-68
3. Travis, and Sobin. Histologic typing of lung and pleural tumors: international histologic classification of tumorurs (no. 1) (1999), Springer-Verlag, New York, NY
4. McMullan D.M., and Wood D.E. Pulmonary carcinoid tumors. Semin Thorac Cardiovasc Surg 15 (2003) 289-300
5. Fink G., Krelbaum T., Yellin A., Bendayan D., Saute M., Glazer M., et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 119 (2001) 1647-1651
6. Godwin II J.D. Carcinoid tumors. An analysis of 2837 cases. Cancer 36 (1975) 560-569
7. Crocetti E., and Paci E. Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. Eur J Cancer Prev 12 (2003) 191-194
8. Taeger D., Sun Y., Keil U., and Straif K. A standalone windows application for computing exact person-years, standardised mortality ratios and confidence intervals in epidemiological studies. Epidemiology 11 (2000) 607-608
9. Limper A.H., Carpenter P.C., Scheithauer B., and Staats B.A. The cushing syndrome induced by bronchial carcinoid tumors. Ann Intern Med 117 (1992) 209-214
10. Ries Lag E.M., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Mariotto A., et al. In: Ries Lag E.M., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Mariotto A., Fay M.P., Feuer E.J., and Edwards B.K. (Eds). SEER cancer statistics review, 1975-2002 (2005), National Cancer Institute, Bethesda, MD
11. Weiss J.R., Moysich K.B., and Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 20-26
12. Boffetta P., and Kaldor J.M. Secondary malignancies following cancer chemotherapy. Acta Oncol 33 (1994) 591-598
13. McClure J.A., and Higgins C.C. Bilateral carcinoma of male breast after estrogen therapy. J Am Med Assoc 146 (1951) 7-9
14. Sobin L.H., and Sherif M. Relation between male breast cancer and prostate cancer. Br J Cancer 42 (1980) 787-790
15. Wilson S.E., and Hutchinson W.B. Breast masses in males with carcinoma of the prostate. J Surg Oncol 8 (1976) 105-112
16. Baba M., Higaki N., Ishida M., Kawasaki H., Kasugai T., and Wada A. A male patient with metachronous triple cancers of small cell lung, prostate and breast. Breast Cancer 9 (2002) 170-174
17. Thellenberg C., Malmer B., Tavelin B., and Gronberg H. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 169 (2003) 1345-1348
18. Valeri A., Fournier G., Morin V., Morin J.F., Drelon E., Mangin P., et al. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 86 (2000) 883-887
19. Metz D.C., Jensen R.T., Bale A.E., Skarulis M.C., Eastman R.C., Nieman L., et al. Multiple endocrine neoplasia type I. Clinical features and management. In: Bilezikian J.P., Levine M.A., and Marcus R. (Eds). The parathyroids (1994), Raven Press Publishing Co., New York 591-646
20. Debelenko L.V., Brambilla E., Agarwal S.K., Swalwell J.I., Kester M.B., Lubensky I.A., et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6 (1997) 2285-2290
21. Jakobovitz O., Nass D., DeMarco L., Barbosa A.J., Simoni F.B., Rechavi G., et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 81 (1996) 3164-3167
22. Marx S.J. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 5 (2005) 367-375
23. Oliveira A.M., Tazelaar H.D., Wentzlaff K.A., Kosugi N.S., Hai N., Benson A., et al. Familial pulmonary carcinoid tumors. Cancer 91 (2001) 2104-2109
24. Hemminki K., and Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92 (2001) 2204-2210
25. Modlin I.M., Lye K.D., and Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 (2003) 934-959
26. Habal N., Sims C., and Bilchik A.J. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 75 (2000) 310-316
27. In: Ries Lag E.M., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Mariotto A., et al. (Eds). SEER cancer statistics review, 1975-2002 (2005), National Cancer Institute, Bethesda, MD